Form 4/A for BHVN Biohaven Ltd.
Accepted 2022-10-05 00:00:00 ET · period of report 2022-10-03 · accession 0001562180-22-007102 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2022-10-05 | 2022-10-03 | BHVN | CHILDS JOHN W | Dir | J - Other | $0.00 | +1.51M | 1.52M | +32,809% | $0 |
| AI | 2022-10-05 | 2022-10-03 | BHVN | CHILDS JOHN W | Dir | J - Other | $0.00 | +5,000 | 5,000 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2022-10-03 | J | A | 1,512,500 | $0.00 | 1,517,110 | D By John W Childs 2013 Revocable Trust | — | — | (F1) Represents common shares of the Issuer ("Common Shares") acquired by the Reporting Person in a pro rata distribution by Biohaven Pharmaceutical Holding Company Ltd.. ("RemainCo") to holders of its common shares (the "Distribution") pursuant to the Separation and Distribution Agreement (the "Separation Agreement"), dated as of May 9, 2022, by and among RemainCo, the Issuer, and Pfizer Inc. ("Pfizer"). (F2) This amendment is being filed to correct the form of ownership reported in the Form 4 filed on October 5, 2022 (the "Original Form 4"). The Original Form 4 inadvertently incorrectly reported that all Common Shares acquired were directly held by the Reporting Person; however, as reflected in this amendment, a portion of the Shares acquired were indirectly held by the Reporting Person in the John W. Childs 2013 Revocable Trust. There were no other changes made to the information in the Original Filing. |
| 2 | Common | Common Shares | 2022-10-03 | J | A | 5,000 | $0.00 | 5,000 | I | — | — | (F2) This amendment is being filed to correct the form of ownership reported in the Form 4 filed on October 5, 2022 (the "Original Form 4"). The Original Form 4 inadvertently incorrectly reported that all Common Shares acquired were directly held by the Reporting Person; however, as reflected in this amendment, a portion of the Shares acquired were indirectly held by the Reporting Person in the John W. Childs 2013 Revocable Trust. There were no other changes made to the information in the Original Filing. |